Immunobullous diseases, prothrombotic state, and COVID-19: Role of prophylactic anticoagulation in bullous pemphigoid and pemphigus.

Anuragi, Ramesh Pratap; Kansal, Naveen Kumar

Anuragi, Ramesh Pratap; Kansal, Naveen Kumar.

Anuragi RP; Department of Dermatology and Venereology, All India Institute of Medical Sciences, Rishikesh, India.
Kansal NK; Department of Dermatology and Venereology, All India Institute of Medical Sciences, Rishikesh, India.

Dermatol Ther ; 33(6): e14361, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-808089

Subject(s)

Anticoagulants/administration & dosage; COVID-19 Drug Treatment; Pemphigoid, Bullous/prevention & control; Pemphigus/prevention & control; Thrombosis/prevention & control; COVID-19/diagnosis; COVID-19/mortality; Comorbidity; Humans; Pemphigoid, Bullous/diagnosis; Pemphigoid, Bullous/mortality; Pemphigus/diagnosis; Pemphigus/mortality; Risk Assessment; Risk Factors; Thrombosis/diagnosis; Thrombosis/mortality; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Pemphigoid, Bullous / Pemphigus / COVID-19 Drug Treatment / Anticoagulants Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14361

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google